Bruce Colston Trapnell MD
Critical Care Medicine
Professor, Pediatrics, University of Cincinnati College of Medicine
Join to View Full Profile
222 Piedmont AveSte 6000Cincinnati, OH 45219
Phone+1 513-475-7521
Fax+1 513-475-7327
Dr. Trapnell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1989- Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1988
Ohio State University HospitalResidency, Internal Medicine, 1984 - 1987
University of Maryland School of MedicineClass of 1984
Certifications & Licensure
OH State Medical License 1998 - 2027
LA State Medical License 2021 - 2022
DC State Medical License 1992 - 1998
MD State Medical License 1987 - 1991
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Clinical Trials
- Efficacy and Safety of Sirolimus in LAM Start of enrollment: 2006 Dec 01
- Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection Start of enrollment: 2008 Nov 01
- Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- The burden of autoimmune pulmonary alveolar proteinosis: a systematic review.Cormac McCarthy, Francesco Bonella, Tisha Wang, Yoshikazu Inoue, Brian Robinson
European Respiratory Review. 2026-04-01 - Pharmacokinetics and pharmacodynamics of inhaled molgramostim in healthy people.Bruce C Trapnell, Brenna C Carey, Brian R Robinson
BMJ Open Respiratory Research. 2025-09-18 - 3 citationsPhase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis.Bruce C Trapnell, Yoshikazu Inoue, Francesco Bonella, Tisha Wang, Cormac McCarthy
The New England Journal of Medicine. 2025-08-21
Journal Articles
- Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar ProteinosisBruce Trapnell, MD, New England Journal of Medicine
Press Mentions
HMN 2025: How Molgramostim Is Beneficial in Autoimmune Pulmonary Alveolar ProteinosisAugust 24th, 2025- Inhaled Molgramostim Promising for Autoimmune Pulmonary Alveolar Proteinosis: Phase 3 Trial ShowsAugust 22nd, 2025
- Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the European Respiratory Society (ERS) Congress 2024September 8th, 2024
Grant Support
- Interdisciplinary Training in Genome SciencesUNIVERSITY OF WASHINGTON1995–2030
- Technology to understand genetic variant effects in contextUNIVERSITY OF WASHINGTON2019–2029
- Versatile, exponentially scalable methods for single cell molecular profilingUNIVERSITY OF WASHINGTON2019–2028
- New software tools for differential analysis of single-cell genomics perturbation experimentsUNIVERSITY OF WASHINGTON2023–2027
- Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)CINCINNATI CHILDRENS HOSP MED CTR2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
